Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma

NCT03413436 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

733

Enrollment

OTHER_GOV

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: Lobaplatin
DRUG: Cisplatin

Sponsor

Henan Cancer Hospital